| 000 | 01826 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513123816.0 | ||
| 264 | 0 | _c19970915 | |
| 008 | 199709s 0 0 eng d | ||
| 022 | _a8750-7587 | ||
| 024 | 7 |
_a10.1152/jappl.1997.83.2.583 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChiang, C H | |
| 245 | 0 | 0 |
_aPGE1, dexamethasone, U-74389G, or Bt2-cAMP as an additive to promote protection by UW solution in I/R injury. _h[electronic resource] |
| 260 |
_bJournal of applied physiology (Bethesda, Md. : 1985) _cAug 1997 |
||
| 300 |
_a583-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine _xpharmacology |
| 650 | 0 | 4 |
_aAllopurinol _xpharmacology |
| 650 | 0 | 4 |
_aAlprostadil _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBucladesine _xpharmacology |
| 650 | 0 | 4 |
_aDexamethasone _xpharmacology |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aGlutathione _xpharmacology |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aInsulin _xpharmacology |
| 650 | 0 | 4 |
_aInterleukin-1 _xmetabolism |
| 650 | 0 | 4 |
_aIschemia _xmetabolism |
| 650 | 0 | 4 |
_aLung _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOrgan Preservation Solutions |
| 650 | 0 | 4 |
_aPregnatrienes _xpharmacology |
| 650 | 0 | 4 | _aPulmonary Circulation |
| 650 | 0 | 4 |
_aRaffinose _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReperfusion Injury _xmetabolism |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 700 | 1 | _aHsu, K | |
| 700 | 1 | _aYan, H C | |
| 700 | 1 | _aHarn, H J | |
| 700 | 1 | _aChang, D M | |
| 773 | 0 |
_tJournal of applied physiology (Bethesda, Md. : 1985) _gvol. 83 _gno. 2 _gp. 583-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1152/jappl.1997.83.2.583 _zAvailable from publisher's website |
| 999 |
_c9242075 _d9242075 |
||